HLS 15RS-655 ORIGINAL
2015 Regular Session
HOUSE BILL NO. 72
BY REPRESENTATIVE MACK
Prefiled pursuant to Article III, Section 2(A)(4)(b)(i) of the Constitution of Louisiana.
CONTROLLED SUBSTANCES: Adds additional substances to Schedule I of the Uniform
Controlled Dangerous Substances Law
1 AN ACT
2To enact R.S. 40:964(Schedule I)(C)(60 through 63), (E)(10 and 11), and (F)(29 through
3 42), relative to the Uniform Controlled Dangerous Substances Law; to add certain
4 substances to Schedule I of the Uniform Controlled Dangerous Substances Law; and
5 to provide for related matters.
6Be it enacted by the Legislature of Louisiana:
7 Section 1. R.S. 40:964(Schedule I)(C)(60 through 63), (E)(10 and 11), and (F)(29
8through 42) are hereby enacted to read as follows:
9 ยง964. Composition of schedules
10 Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S.
11 40:962, consist of the following drugs or other substances, by whatever official
12 name, common or usual name, chemical name, or brand name designated:
13 SCHEDULE I
14 * * *
15 C. Hallucinogenic substances. Unless specifically excepted or unless listed
16 in another schedule, any material, compound, mixture, or preparation, which
17 contains any quantity of the following hallucinogenic substances, or which contains
18 any of their salts, isomers, or salts of isomers, whenever the existence of such salts,
19 isomers, or salts of isomers is possible within the specific chemical designation, for
Page 1 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HLS 15RS-655 ORIGINAL
HB NO. 72
1 purposes of this Paragraph only, the term "isomer" includes the optical, position, and
2 geometric isomers:
3 * * *
4 (60) 4-bromo-2,5-dimethoxyphenethylamine (2C-B)
5 (61) N-(2-methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine
6 (25B-NBOMe)
7 (62) 5-(2-methylaminopropyl)benzofuran (5-MAPB)
8 (63) 4-hydroxy-N-methyl-N-isopropyltryptamine (4-Hydroxy-MIPT)
9 * * *
10 E. Stimulants. Unless specifically excepted, or contained within a
11 pharmaceutical product approved by the United States Federal Food and Drug
12 Administration, or unless listed in another schedule, any material, compound,
13 mixture, or preparation which contains any quantity of the following substances
14 having a stimulant effect on the central nervous system including its salts, isomers,
15 esters, or ethers and salts of isomers, esters, or ethers whenever the existence of such
16 salts, isomers, esters, or ethers and salts of isomers, esters, or ethers is possible
17 within the specific chemical designation:
18 * * *
19 (10) 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one (Alpha-PBT)
20 (11) 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one (Alpha-PVT)
21 F. Synthetic cannabinoids. Unless specifically excepted, or contained within
22 a pharmaceutical product approved by the United States Food and Drug
23 Administration, or unless listed in another schedule, any material, compound,
24 mixture, or preparation, which contains any quantity of a synthetic cannabinoid
25 found to be in any of the following chemical groups, or any of those groups which
26 contain any synthetic cannabinoid salts, isomers, salts of isomers, or nitrogen-
27 heterocyclic analogs, whenever the existence of such salts, isomers, salts of isomers,
28 or nitrogen-heterocyclic analogs is possible within the specific chemical groups:
29 * * *
Page 2 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HLS 15RS-655 ORIGINAL
HB NO. 72
1 (29) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-
2 methylbutanoate
3 (30) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
4 indazole-3-carboxamide
5 (31) N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
6 (32) naphthalen-1-yl-1-pentyl-1H-indazole-3-carboxylate
7 (33) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indole-
8 3-carboxamide
9 (34) 1-(5-fluoropentyl)N-naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-
10 carboxamide
11 (35) methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3-methyl-
12 butanoate
13 (36) methyl 2-(1-pentyl-1H-indazole-3-carboxamido)-3-methylbutanoate
14 (37) 1-(5-fluoropentyl)-N-(quinolin-8-yl)-1H-indole-3-carboxamide
15 (38) N-fenchyl-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide
16 (39) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
17 dimethylbutanoate
18 (40) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
19 dimethylbutanoate
20 (41) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-
21 dimethylbutanoate
22 (42) naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone
23 * * *
24 Section 2. This Act shall become effective upon signature by the governor or, if not
25signed by the governor, upon expiration of the time for bills to become law without signature
26by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana. If
27vetoed by the governor and subsequently approved by the legislature, this Act shall become
28effective on the day following such approval.
Page 3 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions. HLS 15RS-655 ORIGINAL
HB NO. 72
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 72 Original 2015 Regular Session Mack
Abstract: Adds 20 substances to Schedule I of the Uniform Controlled Dangerous
Substances Law.
Present law provides for classification of controlled dangerous substances in Schedules I
through V.
Proposed law adds 20 substances to the list of Schedule I controlled dangerous substances.
Effective upon signature of governor or lapse of time for gubernatorial action.
(Adds 40:964(Schedule I)(C)(60-63), (E)(10 and 11), and (F)(29-42))
Page 4 of 4
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.